These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 23265409)

  • 1. N-acetylcysteine in bulimia nervosa--open-label trial.
    Guerdjikova AI; Blom TJ; Mori N; McElroy SL
    Eat Behav; 2013 Jan; 14(1):87-9. PubMed ID: 23265409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zonisamide in the treatment of bulimia nervosa: an open-label, pilot, prospective study.
    Guerdjikova AI; Blom TJ; Martens BE; Keck PE; McElroy SL
    Int J Eat Disord; 2013 Nov; 46(7):747-50. PubMed ID: 23893331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memantine in the treatment of binge eating disorder: an open-label, prospective trial.
    Brennan BP; Roberts JL; Fogarty KV; Reynolds KA; Jonas JM; Hudson JI
    Int J Eat Disord; 2008 Sep; 41(6):520-6. PubMed ID: 18433015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective binge eating with compensatory behaviors: a variant presentation of bulimia nervosa.
    Watson HJ; Fursland A; Bulik CM; Nathan P
    Int J Eat Disord; 2013 Mar; 46(2):119-26. PubMed ID: 22911884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol and rationale for a randomized double-blinded crossover trial of phentermine-topiramate ER versus placebo to treat binge eating disorder and bulimia nervosa.
    Dalai SS; Adler S; Najarian T; Safer DL
    Contemp Clin Trials; 2018 Jan; 64():173-178. PubMed ID: 29038069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and physiological response to a test meal in purging disorder and bulimia nervosa.
    Keel PK; Wolfe BE; Liddle RA; De Young KP; Jimerson DC
    Arch Gen Psychiatry; 2007 Sep; 64(9):1058-66. PubMed ID: 17768271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating purging and nonpurging bulimia nervosa and binge eating disorder.
    Núñez-Navarro A; Jiménez-Murcia S; Alvarez-Moya E; Villarejo C; Díaz IS; Augmantell CM; Granero R; Penelo E; Krug I; Tinahones FJ; Bulik CM; Fernández-Aranda F
    Int J Eat Disord; 2011 Sep; 44(6):488-96. PubMed ID: 20872757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, placebo-controlled crossover trial of phentermine-topiramate ER in patients with binge-eating disorder and bulimia nervosa.
    Safer DL; Adler S; Dalai SS; Bentley JP; Toyama H; Pajarito S; Najarian T
    Int J Eat Disord; 2020 Feb; 53(2):266-277. PubMed ID: 31721257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial.
    Guerdjikova AI; McElroy SL; Welge JA; Nelson E; Keck PE; Hudson JI
    Int Clin Psychopharmacol; 2009 May; 24(3):150-8. PubMed ID: 19357528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the use of CD-Rom CBT for bulimia nervosa and binge eating disorder in an NHS adult outpatient eating disorders service.
    Graham L; Walton M
    Behav Cogn Psychother; 2011 Jul; 39(4):443-56. PubMed ID: 21208485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder.
    McElroy SL; Guerdjikova AI; Blom TJ; Crow SJ; Memisoglu A; Silverman BL; Ehrich EW
    Int J Eat Disord; 2013 Apr; 46(3):239-45. PubMed ID: 23381803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polaprezinc (Zinc-L-Carnosine Complex) as an Add-on Therapy for Binge Eating Disorder and Bulimia Nervosa, and the Possible Involvement of Zinc Deficiency in These Conditions: A Pilot Study.
    Sakae K; Suka M; Yanagisawa H
    J Clin Psychopharmacol; 2020; 40(6):599-606. PubMed ID: 33044355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled comparison of family-based treatment and supportive psychotherapy for adolescent bulimia nervosa.
    le Grange D; Crosby RD; Rathouz PJ; Leventhal BL
    Arch Gen Psychiatry; 2007 Sep; 64(9):1049-56. PubMed ID: 17768270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium oxybate in the treatment of binge eating disorder: an open-label, prospective study.
    McElroy SL; Guerdjikova AI; Winstanley EL; O'Melia AM; Mori N; Keck PE; Hudson JI
    Int J Eat Disord; 2011 Apr; 44(3):262-8. PubMed ID: 20209489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial.
    McElroy SL; Guerdjikova AI; Winstanley EL; O'Melia AM; Mori N; McCoy J; Keck PE; Hudson JI
    Int J Eat Disord; 2011 Jan; 44(1):81-90. PubMed ID: 21080416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personality pathology in purging disorder and bulimia nervosa.
    Brown TA; Haedt-Matt AA; Keel PK
    Int J Eat Disord; 2011 Dec; 44(8):735-40. PubMed ID: 21321987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of size in defining binge eating episodes in bulimia nervosa.
    Keel PK; Mayer SA; Harnden-Fischer JH
    Int J Eat Disord; 2001 Apr; 29(3):294-301. PubMed ID: 11262508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Illness perception in bulimia nervosa.
    DeJong H; Hillcoat J; Perkins S; Grover M; Schmidt U
    J Health Psychol; 2012 Apr; 17(3):399-408. PubMed ID: 21859799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective and subjective binge eating in underweight eating disorders: associated features and treatment outcome.
    Dalle Grave R; Calugi S; Marchesini G
    Int J Eat Disord; 2012 Apr; 45(3):370-6. PubMed ID: 21656542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacotherapy in eating disorders: a systematic analysis.
    Riedl A; Becker J; Rauchfuss M; Klapp BF
    Psychopharmacol Bull; 2008; 41(1):59-84. PubMed ID: 18362872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.